Asset Details
Do you wish to reserve the book?
Exploring PKMYT1 as a potential marker for colorectal cancer progression through bioinformatics analyses and experimental validation
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Exploring PKMYT1 as a potential marker for colorectal cancer progression through bioinformatics analyses and experimental validation
Do you wish to request the book?
Exploring PKMYT1 as a potential marker for colorectal cancer progression through bioinformatics analyses and experimental validation
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Exploring PKMYT1 as a potential marker for colorectal cancer progression through bioinformatics analyses and experimental validation
2025
Overview
Colorectal cancer (CRC) is a malignant tumor with high morbidity and mortality rates worldwide and only presents symptoms in later stage; no ideal biomarker is available for the early diagnosis of CRC. Therefore, it is important to explore novel molecules that significantly contribute to CRC progression. The cohort contains different stages of CRC were downloaded and comprehensive bioinformatics analyses were performed by Mfuzz, Protein–Protein Interaction (PPI), MCODE, ESTIMATE, and ssGSEA.The results revealed that Protein Kinase, Membrane Associated Tyrosine/Threonine 1 (PKMYT1) served as a functional hub gene and its high expression might be associated with an immunosuppressive microenvironment, therapeutic sensitivity and tumor progression. PKMYT1-related genes are linked to DNA replication, the cell cycle, and mismatch repair, indicating PKMYT1 functions as an oncogene and potential biomarker in CRC development. Moreover, in vitro experimental investigation was conducted and the data found that CRC tumor tissues and cells have elevated PKMYT1 expression. Knockdown of PKMYT1 by siRNAs significantly impaired the proliferation, cell cycling, migration, and invasion of CRC cells. In summary, this study demonstrated that PKMYT1 may be a promising target for therapeutic intervention and play a significant role in the development of CRC.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ 631/80
/ 692/4028
/ 692/53
/ Biomarkers, Tumor - genetics
/ Biomarkers, Tumor - metabolism
/ Cell Proliferation - genetics
/ Colorectal Neoplasms - genetics
/ Colorectal Neoplasms - metabolism
/ Colorectal Neoplasms - pathology
/ Computational Biology - methods
/ CRC
/ Gene Expression Regulation, Neoplastic
/ Humanities and Social Sciences
/ Humans
/ Kinases
/ Membrane Proteins - genetics
/ Membrane Proteins - metabolism
/ PKMYT1
/ Protein Serine-Threonine Kinases - genetics
/ Protein Serine-Threonine Kinases - metabolism
/ Protein-Tyrosine Kinases - genetics
/ Protein-Tyrosine Kinases - metabolism
/ Proteins
/ Science
/ siRNA
/ Tumors
